9:00am - 5:00pm

Office Hours Mon. - Fri.

800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition

Malignant Mesothelioma

Estimated Enrollment: 6

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: CDR0000066157|P30CA006927|FCCC-96087|NCI-G98-1401

Study First Received: November 1, 1999

Last Updated: April 16, 2013

Estimated Primary Completion Date: December 1999

Primary Outcome Measures:

Sponsors and Collaborators:

Fox Chase Cancer Center|National Cancer Institute (NCI)

Result Received: No Study Results Posted

Website Link: https://ClinicalTrials.gov/show/NCT00003263

Was this article helpful?
Views: 50